Alphatec Holdings

ATEC

Market cap $2.37B

Craig E. Hunsaker, EVP, People & Culture at Alphatec Holdings, sold 32,584 shares for a transaction value of $679,050.56 at $20.84 per share on Dec. 10, 2025. The sale represented 2.53% of Hunsaker's direct holdings, reducing his stake from 1,289,142 to 1,256,558 shares.

Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md.

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended De.

Miles Patrick, the CEO of Alphatec Holdings, sold 100,000 shares of the company for about $2.1 million, according to a recent Form 4. This sale represented 1.82% of Miles Patrick's direct holdings, reducing direct ownership to 5.14 million shares.

COO Scott Lish sold 19,900 shares for a transaction value of $390,836 on Dec. 16, 2025. The sale reduced direct ownership to 641,432 shares (0.43% of shares outstanding).

Alphatec stock is up 118% year to date on quarterly results that beat expectations. Although currently unprofitable, the company is expecting full-year positive free cash flow in 2025.

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologi.

As of Oct. 31, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Alphatec Holdings, Inc. ( ATEC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Patrick Miles - Executive Chairman, CEO & President J. Koning - Executive VP & CFO Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Young Li - Jefferies LLC, Research Division Anna Runci - Piper Sandler & Co., Research Division K.